Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Mining, quarrying, and oil and gas extraction tags : Trial save search
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
Published: 2024-03-19 (Crawled : 09:00) - globenewswire.com
XRTX | News | $2.98 1.36% -2.41% 11K
|
Mining, Quarrying, and Oil and ...
|
| O: 10.1%
H: 0.37%
C: -7.3%
trial
Portage Biotech Announces First Patient Dosed in Phase 1a Trial of PORT-6 in Select Solid Tumors
Published: 2023-06-26 (Crawled : 12:20) - globenewswire.com
PRTG | $0.2502 3.13% 8.45% 190K
|
Mining, Quarrying, and Oil and ...
|
| O: -5.51%
H: 5.51%
C: 5.2%
biotech tumors trial
Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual Meeting
Published: 2023-06-05 (Crawled : 12:20) - globenewswire.com
PRTG | $0.2502 3.13% 8.45% 190K
|
Mining, Quarrying, and Oil and ...
|
| O: 2.47%
H: 17.65%
C: 0.8%
lung melanoma biotech cancer cell treatment meeting trial
XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial
Published: 2023-01-19 (Crawled : 12:20) - globenewswire.com
XRTX | News | $2.98 1.36% -2.41% 11K
|
Mining, Quarrying, and Oil and ...
|
| O: 37.97%
H: 14.81%
C: -19.44%
oxy-101 topline trial positive results
UroGen Announces New Data from the OLYMPUS Trial that Shows Median Durability of Response of 28.9 Months for JELMYTO®, the Only Non-Surgical, Chemoablative Treatment for Adults with Low-Grade Upper Tra...
Published: 2022-12-02 (Crawled : 13:00) - biospace.com/
WDH | $1.2 0.84% 0.0% 380K
|
Finance and Insurance
|
| O: -3.09%
H: 6.37%
C: 2.55%
VNDA | $4.56 -1.51% -1.31% 1.1M
|
Health Technology
|
| O: -0.55%
H: 0.64%
C: 0.09%
URGN | $14.21 -2.2% -2.04% 97K
|
Health Technology
|
| O: -1.49%
H: 3.84%
C: -2.44%
SNDX | $20.79 -0.86% -0.87% 370K
|
Health Technology
|
| O: -0.16%
H: 1.12%
C: 0.32%
GTHX | $3.99 -4.77% -5.28% 340K
|
Health Technology
|
| O: -2.22%
H: 9.27%
C: 7.69%
ACET | News | $1.875 -10.71% -12.3% 1.3M
|
Health Technology
|
| O: -1.13%
H: 5.01%
C: 4.84%
jelmyto treatment trial response
XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics StudyXRX-OXY-101 Study will inform the dose choice in the upcoming Phase 3 Clinical Trial
Published: 2022-11-28 (Crawled : 13:00) - biospace.com/
XRTX | News | $2.98 1.36% -2.41% 11K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.73%
H: 6.19%
C: -3.08%
oxy-101 trial study
Portage Biotech Announces Clinical Trial Collaboration Agreement with Merck
Published: 2022-11-08 (Crawled : 13:00) - globenewswire.com
PRTG | $0.2502 3.13% 8.45% 190K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.78%
H: 4.04%
C: 1.4%
collaboration biotech trial agreement
XORTX Announces Positive Topline Results from Pharmacokinetics Bridging Clinical TrialClinical Trial Shows Substantially Improved Bioavailiability
Published: 2022-07-13 (Crawled : 13:00) - biospace.com/
XRTX | News | $2.98 1.36% -2.41% 11K
|
Mining, Quarrying, and Oil and ...
|
| O: 72.13%
H: 6.19%
C: -13.81%
topline trial positive results
COVID-19 Nucleic Acid Amplification Tests (NAATs) Medical Devices Pipeline Market Report 2021: Analysis by Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Clinical Trials
Published: 2022-02-11 (Crawled : 21:00) - prnewswire.com
GWHP | $0.0001 4000.0% 86K
|
Mining, Quarrying, and Oil and ...
| Email alert
Add to watchlist
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
| Email alert
Add to watchlist
TMO | News | $577.39 0.49% -0.38% 1.7M
|
Health Technology
| Email alert
Add to watchlist
covid-19 als ces trials device trial approval covid clinical trials report test
TotalEnergies to Acquire SunPower's Commercial & Industrial Solar Business
Published: 2022-02-10 (Crawled : 08:00) - prnewswire.com
TTE | $72.74 -0.32% -0.18% 1.1M
|
Mining, Quarrying, and Oil and ...
|
| O: -1.29%
H: 1.89%
C: 0.56%
TTFNF | $73.47 1.73% -3.76% 1K
|
Energy Minerals
|
| O: -1.72%
H: 1.75%
C: -0.47%
SPWR | $1.94 -1.02% -1.03% 4.6M
|
Producer Manufacturing
|
| O: -2.32%
H: 5.23%
C: -0.24%
solar trial talen commercialization
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Zymergen (ZY) Investors to Contact Firm's Attorneys Now, Securities Class Action Filed
Published: 2021-08-06 (Crawled : 14:00) - prnewswire.com
ZY | $2.43 0.0%
|
Mining, Quarrying, and Oil and ...
|
| O: -8.24%
H: 0.0%
C: 0.0%
trial merge
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Zymergen (ZY) Investors to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations
Published: 2021-08-05 (Crawled : 14:00) - prnewswire.com
ZY | $2.43 0.0%
|
Mining, Quarrying, and Oil and ...
|
| O: 20.97%
H: 54.91%
C: 44.79%
trial merge
Portage Biotech Highlights Initiation of the Invincible Trial, a Phase 2 Early Stage Breast Cancer Study from Intensity Therapeutics
Published: 2021-03-25 (Crawled : 15:15) - biospace.com/
PRTG | $0.2502 3.13% 8.45% 190K
|
Mining, Quarrying, and Oil and ...
|
| O: 3.59%
H: 0.0%
C: -3.4%
phase 2 cancer biotech iot breast cancer trial
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.